The clinical usefulness of prostate specific antigen: update 1994.

@article{Partin1994TheCU,
  title={The clinical usefulness of prostate specific antigen: update 1994.},
  author={Alan W. Partin and Joseph E. Oesterling},
  journal={The Journal of urology},
  year={1994},
  volume={152 5 Pt 1},
  pages={1358-68}
}
In conclusion, PSA is the first prostate specific serum marker of clinical usefulness in urology. It represents a valuable clinical tool that has improved our ability to detect early prostate cancer and to monitor response to therapy. While large PSA screening studies have demonstrated an appreciable increase in the detection of organ confined, potentially curable prostate cancers, no study to date has yet demonstrated that the increased detection rate will decrease the prostate cancer-specific… CONTINUE READING

From This Paper

Topics from this paper.
99 Citations
11 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 99 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Prostate specific antigen expression by various tumors

  • M. Levesque, H. Yu, M. D'Costa, E. P. Diamandis
  • J. Clin. Lab Anal.,
  • 1995
1 Excerpt

Similar Papers

Loading similar papers…